Atherosclerosis risk in HIV-infected patients: The influence of hepatitis C virus co-infection

Atherosclerosis

Volumn 222, Issue 1, 2012, Pages 274-277

  Sosner, Philippe ^a,b,c   Wangermez, Marc ^a   Chagneau Derrode, Carine ^a   Le Moal, Gwenaël ^a   Silvain, Christine ^a,b  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c INSERM   (France)

Author keywords

Atherosclerosis; Hepatitis C; HIV; Intima media thickness; Liver fibrosis

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYALURONIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SURVEILLANCE; DOPPLER ECHOGRAPHY; FEMALE; FEMORAL ARTERY; FEMORAL ATHEROSCLEROSIS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; INTERMETHOD COMPARISON; LIVER FIBROSIS; MALE; METABOLIC DISORDER; MIXED INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; COINFECTION; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER;

EID: 84859849101     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.02.027     Document Type: Article

References (15)

1. Vassalle C., Masini S., Bianchi F., Zucchelli G.C. Evidence for association between hepatitis C virus seropositivity and coronary artery disease. Heart 2004, 90:565-566.
2. Mancia G., De Backer G., Dominiczak A., et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007, 28:1462-1536.
3. Alberti K.G., Zimmet P., Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005, 366:1059-1062.
4. Wai C.T., Greenson J.K., Fontana R.J., et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003, 38:518-526.
5. Cales P., Oberti F., Michalak S., et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 2005, 42:1373-1381.
6. Sterling R.K., Lissen E., Clumeck N., et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006, 43:1317-1325.
7. Castera L. Use of elastometry (FibroScan) for the non-invasive staging of liver fibrosis. Gastroenterol Clin Biol 2007, 31:524-530.
8. Lorenz M.W., Stephan C., Harmjanz A., et al. Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Atherosclerosis 2008, 196:720-726.
9. Kiechl S., Egger G., Mayr M., et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001, 103:1064-1070.
10. Samaras K., Wand H., Law M., et al. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia. Diabetes Care 2007, 30:113-119.
11. Friis-Moller N., Reiss P., Sabin C.A., et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007, 356:1723-1735.
12. Targher G., Bertolini L., Padovani R., et al. Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. J Hepatol 2007, 46:1126-1132.
13. Aslam F., Alam M., Lakkis N.M. Hepatitis C and carotid atherosclerosis: a retrospective analysis. Atherosclerosis 2010, 209:340-343.
14. Mangili A., Polak J.F., Quach L.A., Gerrior J., Wanke C.A. Markers of atherosclerosis and inflammation and mortality in patients with HIV infection. Atherosclerosis 2011, 214:468-473.
15. Visnegarwala F., Chen L., Raghavan S., Tedaldi E. Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection. J Infect 2005, 50:331-337.